Table S5. Prescription patterns of comorbidity-relevant medication according to sensitivity analyses. (DOC 74 kb
Table S1. A summary of the primary etiologies included in non-IPF ILD group. Table S2. Individual-le...
The league table of the network for the estimation of clinical cure rates of the treatments accordin...
Abstract Background Interstitial lung diseases (ILDs) are associated with a high burden of disease. ...
Table S2. Prescription patterns of comorbidity-relevant medication at the subtype level. (DOC 75 kb
Table S6. Proportion of treated comorbid conditions according to sensitivity analyses. (DOC 60 kb
Table S7. Associations of clinical characteristics and survival within the sensitivity analyses. (DO...
Table S4. Baseline characteristics of the study sample within Sensitivity Analysis 2. (DOC 56 kb
Figure S2. Comorbidity prevalence in main analysis compared with sensitivity analyses. (DOC 104 kb
Table S3. ILD subtype-specific hazard ratios as per the comorbidity-only Cox model. (DOC 97 kb
Figure S3. Pneumoconios-, Drug-associated ILD-, Radiation-asscociated pneumonitis-, Eosinophilic pne...
Treatment modality in treatment group (nâ=â86). Table S2. Comorbidities of study population. Tab...
Comorbidities among respiratory diseases. Figure S1. Comorbidities* between respiratory diseases and...
BACKGROUND: Interstitial lung diseases (ILDs) are associated with a high burden of disease. However,...
Table S4. Adjunctive measures/therapies during at least one day during follow-up in immunocompetent ...
Table S1. International Classification of Disease (ICD) codes, 10th revision, for classification of ...
Table S1. A summary of the primary etiologies included in non-IPF ILD group. Table S2. Individual-le...
The league table of the network for the estimation of clinical cure rates of the treatments accordin...
Abstract Background Interstitial lung diseases (ILDs) are associated with a high burden of disease. ...
Table S2. Prescription patterns of comorbidity-relevant medication at the subtype level. (DOC 75 kb
Table S6. Proportion of treated comorbid conditions according to sensitivity analyses. (DOC 60 kb
Table S7. Associations of clinical characteristics and survival within the sensitivity analyses. (DO...
Table S4. Baseline characteristics of the study sample within Sensitivity Analysis 2. (DOC 56 kb
Figure S2. Comorbidity prevalence in main analysis compared with sensitivity analyses. (DOC 104 kb
Table S3. ILD subtype-specific hazard ratios as per the comorbidity-only Cox model. (DOC 97 kb
Figure S3. Pneumoconios-, Drug-associated ILD-, Radiation-asscociated pneumonitis-, Eosinophilic pne...
Treatment modality in treatment group (nâ=â86). Table S2. Comorbidities of study population. Tab...
Comorbidities among respiratory diseases. Figure S1. Comorbidities* between respiratory diseases and...
BACKGROUND: Interstitial lung diseases (ILDs) are associated with a high burden of disease. However,...
Table S4. Adjunctive measures/therapies during at least one day during follow-up in immunocompetent ...
Table S1. International Classification of Disease (ICD) codes, 10th revision, for classification of ...
Table S1. A summary of the primary etiologies included in non-IPF ILD group. Table S2. Individual-le...
The league table of the network for the estimation of clinical cure rates of the treatments accordin...
Abstract Background Interstitial lung diseases (ILDs) are associated with a high burden of disease. ...
DOI
Add to ORKG